Skip to main content

Proceeding contribution from Lord Hunt of Kings Heath (Labour) in the House of Lords on Tuesday, 20 March 2012. It occurred during Debates on delegated legislation on Misuse of Drugs Act 1971 (Amendment) Order 2012.


Misuse of Drugs Act 1971 (Amendment) Order 2012

My Lords, I am most grateful to the noble Lord, Lord Henley, for his explanation of the instruments and the other negative instruments that are to be seen in the context of this instrument. I congratulate him on his pronunciation— I do not intend to follow him down that route. As the noble Lord said, the Merits Committee has also advised us that the draft instrument supersedes a draft of the same title because of new advice from the Advisory Council on the Misuse of Drugs. I take this opportunity to pay tribute to the work of the advisory committee, which will obviously be taken very seriously by the Grand Committee. I noted in paragraph 8.1 of the Explanatory Memorandum that the consultation process involved consulting the MHRA, which I had the pleasure to establish, and the Department for Business, Innovation and Skills. Were other organisations consulted in that exercise? The explanatory note also refers to guidance to be issued, and I noticed that it makes reference to communicating with young people. Can the noble Lord say a little more about how it is intended to do that? Finally, paragraph 12.1 refers to the fact that the policy is to be monitored and reviewed as part of the drugs strategy. Can he say anything about how the monitoring and review will take place? Other than that, I have great pleasure in supporting the order.


Secondary information

Type
Proceeding contribution
Reference
736 c138GC 
Session
2010-12
Chamber / Committee
House of Lords Grand Committee
Subjects
Drugs Misuse Benzodiazepines
Legislation
Misuse of Drugs Act 1971 (Amendment) Order 2012
Link
View this Proceeding contribution on www.publications.parliament.uk